Dr. Chunsheng Leng, founder of Shanghai Zigang Enterprise Management Co., Ltd. is a prominent leader in China’s recombinant protein and peptide drug fields. With nearly 30 years of experience in biopharmaceutical R&D, large-scale industrialization, product commercialization, and corporate management, Dr. Leng has spearheaded the research, development, and production of numerous gene recombinant human insulin products in China, all with independent intellectual property rights. He has been awarded second place in the State Scientific and Technological Progress Award, honored as a National Model Worker, and is a recipient of the State Council’s Special Allowance.